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Background: Podoconiosis, or non-filarial elephantiasis, is a neglected tropical disease (NTD) characterised by
swelling of the lower legs. When left untreated, this disfiguring condition has a significant social impact. This study
aimed to describe the stigma experience among podoconiosis patients in Dembecha, Northern Ethiopia and assess
potential associations between stigma and sociodemographic determinants.
Methods: The study was conducted in May 2012 in Northern Ethiopia. A questionnaire-based cross-sectional study
design was used and stigma was assessed using a validated podoconiosis stigma scale including ‘felt’ and ‘enacted’
stigma domains. Enacted stigma includes the experience of discrimination such as abuse, loss of employment or
prejudicial attitudes, while felt stigma is the perceived fear of enacted stigma. A multivariable linear regression
model was used to explore determinants that may be associated with stigma.
Results: A total of 346 clinically confirmed podoconiosis patients participated in the study. The total mean score of
all stigma scale items was 30.7 (Range = 0 to 96). There was a higher mean score of scale items in domains of felt
stigma (21.7; Range = 0 to 45) as compared to enacted stigma (9.0; Range = 0 to 51). The total mean score of all
stigma scale items appeared to increase with disease stage. A final adjusted linear regression model found an
association between stigma and factors including monthly income, duration lived in the current residence, and
disease stage, after controlling for confounders.
Conclusion: Podoconiosis is a stigmatized disease with a clear social impact. This paper documented the burden
of podoconiosis-related stigma and identified associated factors. Programs aimed at preventing and treating
podoconiosis should incorporate interventions to mitigate both felt and enacted stigma. Interventions targeting
patients should prioritize those with advanced disease.
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Podoconiosis, or non-filarial elephantiasis, is a neglected
tropical disease (NTD) characterised by swelling of the
lower legs. In addition, affected individuals can develop
disfiguring symptoms such as nodular skin changes, a
mossy appearance around the base of the foot or foul-
smelling wounds. It often affects barefoot subsistence
farmers exposed to irritant volcanic soils [1]. Current
evidence also suggests genetic susceptibility [1,2].* Correspondence: kebededeka@yahoo.com
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reproduction in any medium, provided the orPodoconiosis is found across Asia, South America, and
tropical Africa including Ethiopia where an estimated
one million people are affected. Podoconiosis is a
chronic condition, leading to progressive disability.
However, it is reversible and preventable with hygiene
and the use of shoes [3,4].
When left untreated, this disfiguring condition has a
significant social impact. Affected people often face
forms of severe stigma such as isolation, exclusion from
community events and barriers to employment, educa-
tion, or marriage [5,6]. Podoconiosis is poorly under-
stood by the community and health professionals, and
various misconceptions exist about its aetiology,Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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13% of podoconiosis patients experienced one or more
forms of social stigma [8]. In Southern Ethiopia, more than
50% of community members interviewed in one study
showed stigmatising attitudes towards podoconiosis-
affected individuals while 100% of health professionals
interviewed in a second study held one or more stigmatis-
ing attitudes [7,9]. Fear of further stigmatization among
podoconiosis patients has been found to be a barrier to
consistent shoe use (a control intervention) and participa-
tion in research such as podoconiosis genetic studies
[10,11]. Coping strategies used by patients while facing such
stigma include active or avoidant behaviors and efforts to
change relational meaning [12]. We have previously re-
ported reduction in quality of life among podoconiosis pa-
tients as compared to healthy controls [13].
Stigmatization of podoconiosis patients is a clear ex-
ample of health-related stigma. Health-related stigma
has been described by Weiss et al. as “a social process or
related personal experience characterized by exclusion,
rejection, blame, or devaluation that results from experi-
ence or reasonable anticipation of an adverse social
judgement about a person or group identified with a
particular problem” [14]. This can lead to social, health,
and psychological consequences [15]. In particular,
stigma-related structures of exclusion can lead to harm-
ful delays in diagnosis or treatment-seeking due to fear,
shame, or lack of economic capital (as a result of social
exclusion) [16]. Health-related stigma as described above
can include enacted and felt stigma; enacted stigma in-
cludes the experience of discrimination such as abuse,
loss of employment or prejudicial attitudes [17,18], while
felt stigma is the perceived fear of enacted stigma
[17,19].
Health-related stigma has been described for other
major NTDs including lymphatic filariasis (LF), schisto-
somiasis, onchocerciasis, leishmaniasis, Buruli ulcer and
leprosy [20-29]. Studies have described NTD-related
stigma experiences in a broad range of domains. Stigma
among leprosy patients has been well-studied and pro-
vides examples of stigma in domains such as mobility,
domestic life, interpersonal interactions and relation-
ships, community, social and civic life and other major
life areas [30,31]. For other NTDs, individual studies
have focused on particular stigma experiences such as
social isolation (as in the case of LF and Buruli ulcer) or is-
sues of self-esteem (as in onchocerciasis) [21,27,32]. Indi-
vidual symptoms of NTDs have been noted as the source
of stigma such as haematuria in urinary schistosomiasis,
Buruli ulcer or onchocercal skin lesions, leishmaniasis
scars and LF lymphoedema or hydrocele [22,24-26]. As a
consequence of this stigma, many studies have reported
delayed treatment due to shame and lack of household
support or economic means [15,21,27,33].Potential determinants of stigma related to NTDs have
also been explored. Young age and increasing disease
stage were found to be risk factors for stigma among
various studies. In a study by Yanik et al., younger gen-
erations affected by cutaneous leishmaniasis showed less
acceptance of stigma than older adults [34]. Age and so-
cial role appeared to influence social connectedness
among LF patients in a study by Person et al. [29]. In
the same study, stigma appeared to be correlated with
increasing disease stage [29]. Higher grades of lymphoe-
dema and hydrocele were also associated with increased
stigma in a study by Kumari et al. [35]. Other studies
found that stigma scores were not associated with any
personal characteristics or disease factors as described
by Brieger et al. in the case of onchocerciasis [32]. Vlass-
off et al. looked particularly at gender and stigma of
onchocercal skin disease across Africa, but found no sig-
nificant differences [25]. This study aimed to determine
the scale of stigma among podoconiosis patients in
Dembecha, Northern Ethiopia and assess potential asso-
ciations between stigma and other factors.
Methods
The study was conducted in May 2012 in Dembecha
woreda (district), Northern Ethiopia. Dembecha is part
of West Gojjam zone in Amhara Region State and has a
population of 142,118. The woreda consists of 29 kebeles
(smallest administrative unit) and the majority of residents
come from the Amhara ethnic group (99.82%), use
Amharic as their first language (99.87%), and identify them-
selves as Ethiopian Orthodox Christians (98.47%) [36].
A questionnaire-based cross-sectional study design
was used. Stigma was assessed using a validated podoco-
niosis stigma scale in the domains of felt (15 scale items)
and enacted stigma (17 scale items). In previous testing,
the scale showed good consistency (i.e. Cronbach’s alpha
greater than 0.7) and satisfactory validity with modest cor-
relation between items. Significant correlation existed be-
tween felt and enacted stigma patient scales (Spearman’s
r = 0.892, p < 0.001) [17].
Podoconiosis treatment services (patient self-help
groups, education on foot hygiene, wound care, banda-
ging, minor surgery and provision of subsidized shoes),
were offered for the first time in the study area during
2011 as part of the International Orthodox Christian
Charities (IOCC) Gojjam Podoconiosis Project. Prior to
these services, a baseline survey was conducted in Dembe-
cha woreda and identified 1,704 cases of podoconiosis
from 51,017 screened individuals (i.e. prevalence in indi-
viduals greater than 15 years was 3.3%) [6]. Seven kebeles
in Dembecha woreda with the highest prevalence esti-
mates from the baseline survey were selected for this
study. Patients included in the previous baseline survey
were then contacted again for this study. Convenience
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from each kebele list (i.e. a near-total sample). Random se-
lection was not feasible due to the distribution of patients
over considerable distances within each kebele. Individuals
under 15 years were excluded. The total study sample in-
cluded 346 clinically confirmed adult podoconiosis
patients.
The questionnaire was piloted before the study using
seven patients within the town of Debre Markos. Trans-
lation and understanding of the scale was reviewed and
corrections were made to ensure clarity. Data collection
was conducted for five days from 3rd to 7th May 2012.
Seven nurses (one per kebele) were responsible for data
collection. These nurses were familiar with the local
area, fluent in Amharic, and had sufficient medical back-
ground knowledge. They received training on podoco-
niosis basics, the objective of the study, the potential
impacts of the study, details about the podoconiosis
scale, patient selection and informed consent. The
nurses used the scales for structured interviews because
patient low literacy levels prevented self-completion.
Additionally, three supervisors, oversaw the data collec-
tion process, answered queries and reviewed scale
reliability.
SPSS-19 was used for the data analysis. Data were
checked, cleaned, and missing scale values were replaced
with the items’ average. Data were analyzed using
STATA version 11. A descriptive analysis was first con-
ducted to define the basic characteristics of the podoco-
niosis cases. Stigma was estimated by mean scores in: (1)
total stigma scale items, (2) domains of felt stigma only,
and (3) domains of enacted stigma only. Stigma was then
considered the main outcome and mean scores were cal-
culated for comparison with previous podoconiosis
stigma studies conducted in other Ethiopian regions.
The Wilcoxon rank sum and Kruskal-Wallis tests were
used to analyse mean stigma scale scores according to
sociodemographic determinants and other factors.
Stigma scores were treated as continuous variables and a
multivariable linear regression model was used to ex-
plore factors that may be associated with stigma. All var-
iables were included in the model according to
conceptual background knowledge and cross-tabulations
(ie. age, education, marital status, place of residence,
duration lived in current residence, socioeconomic sta-
tus, and disease stage). All variables remained in the
final model with p-values less than 0.05 were considered
significantly associated with overall stigma.
Ethical approval was obtained from Amhara Regional
Health Bureau in Northern Ethiopia and the Research
Governance and Ethics Committee of Brighton and Sus-
sex Medical School. Written informed consent was
sought from all participants including thumbprints for
those unable to sign. Consent from parents or guardianswas obtained for individuals aged <18 years. All data
were anonymised and kept on a password-protected
area. Identifiable information was stored separately from
other research data.
Results
The descriptive analysis can be seen in Table 1. The age
of cases ranged from 15 to 80 years and the mean was
45.7 years (standard deviation [SD] =13.2). There were
more female cases (59.8%) than male, and the majority
lived in a rural area (98.0%), worked as farmers (72.8%)
and were illiterate (76.6%). Approximately half of the
cases were married (57.2%) and had no formal schooling
(56.8%). All of the cases had an Amhara ethnic back-
ground (100%). Household income ranged from 0 to
1500 ETB per month and the mean was 285.14 ETB per
month (SD = 206.42).
The total mean score of all stigma scale items was 30.7
(Range = 0 to 96) as seen in Table 2. There was a higher
mean score of scale items in domains of felt stigma
(21.7; Range = 0 to 45) as compared to enacted stigma
(9.0; Range = 0 to 51). In the felt stigma domains, the
highest mean score was found in scale items related to
interpersonal interactions (17.6; Range = 0 to 21). In the
enacted stigma domains, the highest mean score was
found in scale items related to community, social, and
civic life (3.9; Range = 0 to 18). The felt and enacted
stigma scales correlated significantly (Spearman’s r =
0.626; p < 0.001). As seen in Figure 1, the total mean score
of all stigma scale items appeared to increase with disease
stage, peaking at stage 4 and decreasing at stage 5.
Mean stigma scores according to sociodemographic
determinants and other factors are summarised in
Table 3: Those living in an urban area had a statistically
significant higher stigma score across total stigma scale
items, in domains of felt stigma, and in domains of
enacted stigma than those living in a rural area (p = 0.013,
p = 0.006, p = 0.036, respectively). A statistically significant
difference was also found across disease stages in total
stigma scale items, in domains of felt stigma, and in do-
mains of enacted stigma (p = 0.005, p = 0.002, p = 0.001,
respectively) and across household income groups in do-
mains of enacted stigma only (p = 0.001).
A final adjusted linear regression model was controlled
for age, education, marital status, place of residence,
duration lived in current residence, monthly income,
and disease stage as seen in Table 4. In this model,
podoconiosis patients with a monthly income greater
than the median were predicted to have a 5.18 point
higher total mean stigma score (95% CI: 2.08 to 8.28)
than those with a monthly income of less than the me-
dian (p = 0.001). Patients with disease stages 3 or higher
were predicted to have 5.12 point higher total mean
stigma score (95% CI: 2.06 to 8.18) than those with
Table 1 Basic characteristics of the podoconiosis patients
in Dembecha, Northern Ethiopia, May 2012 (N = 346)
Variables Number (%)
Gender Male 139 (40.2)
Female 207 (59.8)
Age (years) Mean *(SD) 45.74 (13.2)
15–24 10 (2.9)
25–34 63 (18.2)
35–44 79 (22.8)
45–54 92 (26.6)
55–64 75 (21.7)
65+ 27 (7.8)
Area of Residence Rural 339 (98.0)
Urban 7 (2.0)
Occupation Farmer 252 (72.8)
Traders 36 (10.4)
Employed 6 (1.7)
Daily Labourer 21 (6.1)
Housewife 0 (0.0)
Student 4 (1.2)
Jobless 16 (4.6)
Other 11 (3.2)
Ethnicity Amhara 346 (100.0)
Educational status Not literate 265 (76.6)
Able to read and write 46 (13.3)
Primary (grade 1–6) 27 (7.8)
Secondary (grade 7–12) 8 (2.3)
Household Income (Birr/month) Median (range)* 296.8 (0–1500)
1st quintile (poorest) 86 (24.9)
2nd quintile 77 (22.3)
3rd quintile 79 (22.8)
4th quintile 56 (16.2)
5th quintile (richest) 48 (13.9)
Marital Status Married 198 (57.2)
Unmarried 30 (8.7)
Divorced 63 (18.2)
Widowed 55 (15.9)
Other Co–morbidities Yes 64 (18.5)
No 282 (81.5)
Podoconiosis Disease Stage Stage 1 51 (14.9)
Stage 2 175 (51.2)
Stage 3 93 (26.9)
Stage 4 15 (4.3)
Stage 5 8 (2.3)
*Median age = 45 years (interquartile range [IQR] = 35 to 55 years) and median
household income = 296.75 ETB per month (IQR = 107.50 to 370.00 ETB).
Table 2 Mean stigma scale scores from podoconiosis
patients in Dembecha, Northern Ethiopia, May 2012
(N = 346)
Category Mean (SD) 95% CI
Total stigma scale items
Total: Mean score of all stigma scale items
ranging from 0 to 96
30.7 (0.1) 29.3–32.2
Felt stigma: Mean score of scale items
ranging from 0 to 45
21.7 (0.3) 21.2–22.3
Enacted stigma: Mean score of scale items
ranging from 0 to 51
9.0 (0.5) 8.0–10.0
Domains of felt stigma only
Interpersonal interactions: Mean score of
scale items ranging from 0 to 21
17.6 (0.1) 17.3–17.9
Major life areas: Mean score of scale items
ranging from 0 to 15
2.4 (0.2) 2.0–2.8
Community, social, civic life: Mean score
of scale items ranging from 0 to 9
1.8 (0 .1) 1.5–2.0
Domains of enacted stigma only
Interpersonal interactions: Mean score of
scale items ranging from 0 to 11
2.2 (0.1) 1.9–2.5
Major life areas: Mean score of scale items
ranging from 0 to 18
2.8 (0.2) 2.4–3.3
Community, social, civic life: Mean score
of scale items ranging from 0 to 18
3.9 (0.2) 3.6–4.3
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dence in an area increased by one year, the stigma mean
score decreased by 0.13 points (coeff = −0.13: 95%
CI: -0.23 to −0.04) (p = 0.007).
Discussion
This study chose to use the validated podoconiosis
stigma scale consisting of distinct domains: felt and
enacted stigma. As defined by Weiss et al. for NTDs,
the hidden distress model distinguishes enacted stigma
from felt stigma [28]. However, various measurements
or definitions of stigma beyond the hidden distress
model have been used in NTD-related stigma research,
making direct study comparisons difficult [37]. This
study aimed to first describe the stigma experience
among podoconiosis patients by felt or enacted stigma
and then to assess potential associations between stigma
and sociodemographic determinants among other fac-
tors. There was a significantly higher mean stigma score
of scale items in domains of felt stigma (highest in inter-
personal interactions) as compared to enacted (highest
in community, social and civic life). This is comparable
to leprosy where felt stigma appears to be more wide-
spread than enacted stigma [30].
Fewer analytical NTD-stigma studies were found than
descriptive research. In this study, an association was
found between stigma and factors including monthly in-
come, marital status, and disease stage after controlling
Figure 1 Total mean score of stigma according to podoconiosis disease stage among patients in Dembecha, Northern Ethiopia,
May 2012 (N = 346).
Deribe et al. BMC Public Health 2013, 13:1178 Page 5 of 8
http://www.biomedcentral.com/1471-2458/13/1178for confounders. Similarly, disease stage was found to be
associated with stigma among LF patients in other stud-
ies [29,35]. This may be because increased podoconiosis
disease stage is more visible than lower stages. Patients
with advanced disease may not be able to hide from the
community, exacerabating the extent of stigma felt or
experienced. Young age was not found to be a significant
risk factor in this study in contrast to other NTD-stigma
studies [29,34]. Another study on leprosy chose to ex-
plore quality of life as the main outcome and found as-
sociations between decreased quality of life and stigma in
addition to fewer years of education, the presence of de-
formities, and a lower annual income [37]. As shown in
Figure 1, the mean stigma increases up to stage 4 steadily
and decreases among stage 5. This might be due to the
small sample of stage 5 patients rather than an actual trend.
Stigma research on TB and HIV/AIDS also provides
comparisons. A study by Somma et al. explored determi-
nants of TB-related stigma across Malawi, Bangladesh,
and India. In Malawi, never having been married, reduced
income and unemployment were associated with greater
stigma. In India, never having been married and reduced
income were assoiated with greater stigma. In Bangladesh,
female sex, physical weakness and young age were associ-
ated with greater stigma [38]. For HIV/AIDS-related
stigma, a study by Infante et al. identified gender, social
class, and ethnicity as significiant determinants in Mexico
whereas a study by Wong identified ethnicity, age, so-
cioeconomic group, and an urban setting as significant
determinants in Malaysia [39,40]. These results reflect
region-specific differences.In contrast to the TB and HIV/AIDS-related stigma
research [5], this study found that individuals with
higher income experienced or felt more stigma. This
might be partly explained by patients with higher socio-
economic status being more socially and economically
involved exposing them to further stigmatization than
those who use avoidant coping strategies [12]. The dif-
ference in life experience between those with higher and
lower socioeconomic status may significantly differ,
resulting in differences in acceptable thresholds of
stigma between these two groups. In further analysis the
enacted stigma was significantly assoacited with dichoto-
mized income (p = 0.003), whereas there was no assoaci-
tion between felt stigma and dichotomized income (p =
0.747). This needs further research to explore the inter-
play between income and stigma in this study setting. Fi-
nally, duration of stay in the current residence was
found to predict stigma. As the duration increases, the
level of stigma decreases, which might be due to the so-
cial networks established or more familiarity with indi-
vidual patients.
Our finding suggests that felt stigma is more prevalent
than enacted stigma. This might imply that patients tend
to overestimate stigma. Efforts to diminish podoconiosis
stigma should focus on counseling patients to live with
podoconiosis and use a multidisciplinary approach to
develop positive self-image through counseling.
This study had several strengths. The podoconiosis
stigma scale tool used had proven consistency and valid-
ity in Ethiopia, although in a different community [17].
Nurses, with medical backgrounds, language fluency and
Table 3 Mean stigma scale scores according to sociodemographic determinants and other factors among podoconiosis
patients in Northern Ethiopia, May 2012 (N = 346)
Variable Mean stigma scores
Total stigma P-value* Felt stigma P-value* Enacted stigma P-value*
Sex Male 31.4 0.287 22.2 0.269 9.2 0.194
Female 30.3 21.4 8.8
Monthly income 1 (Lowest) 29.0 0.996 21.4 0.996 7.6 0.001
2 30.6 21.7 8.9
3 30.2 21.6 8.6
4 28.4 21.7 6.7
5 (Highest) 37.4 22.7 14.8
Age <45 years 32.8 0.456 22.1 0.456 10.7 0.062
45-64 years 29.5 21.7 7.9
≥65 years 28.1 20.6 7.5
Residence Rural 30.5 0.013 21.6 0.006 8.9 0.036
Urban 39.3 25.6 13.7
Education Illiterate 30.6 0.531 21.6 0.531 9.1 0.794
Up to primary schooling 31.8 22.6 8.6
Up to secondary schooling 30.2 21.6 9.0
Comorbidities Yes 33.2 0.554 22.1 0.965 10.9 0.350
No 30.2 21.6 8.5
Marital Status Married 29.9 0.130 21.6 0.414 8.3 0.114
Unmarried 31.8 21.9 9.9
Disease Stage Stage 1 25.2 0.005 19.7 0.002 5.5 0.001
Stage 2 30.5 21.7 8.8
Stage 3 32.4 22.4 10.0
Stage 4 39.8 24.7 15.1
Stage 5 34.1 22.9 11.3
Time lived in the current residence ≤5 years 36.5 0.804 23.1 0.804 13.1 0.359
6-10 years 31.1 21.9 9.2
11-15 years 31.3 21.2 10.1
>15 years 30.4 21.7 8.7
*Statistical significance was considered p < 0.05. Wilcoxon rank sum and Kruskal-Wallis tests were used as appropriate to derive the p-values.
Table 4 A linear regression analysis of total mean stigma scale scores and sociodemographic determinants among
other factors in podoconiosis patients in Northern Ethiopia, May 2012 (N = 346)*
Variable* Unadjusted coefficient (95% CI) Adjusted coefficient (95% CI)** P-value
Disease stage: Stage 3 or higher 4.73 (1.70 to 7.75) 5.12 (2.06 to 8.18) 0.001*
Monthly income: Greater than median 2.27 (−0.6 to 5.2) 5.18 (2.08 to 8.28) 0.001*
Marital status: Unmarried 1.92 (−1.0 to 4.8) 2.29 (−0.83 to 5.41) 0.149
Age in years 45-64 −2.38 (−5.39 to 0.64) 0.74 (−0.41 to 2.69) 0.671
Age in years > =65 −3.39 (−8.98 to 2.19) 0.58 (−5.67 to 6.83) 0.855
Education: Illiterate 2.56 (−0.87 to 5.98) 1.66 (−1.72 to 5.05) 0.335
Place of residence: Urban 8.75 (−1.43 to 18.93) 8.72 (−1.32 to 18.75) 0.088
Duration lived in the area £ −0.12 ( −0.19 to −0.03) -0.13 (−0.23 to −0.04) 0.007*
*Reference groups: Disease stage (stage 1 and 2), Monthly income (less than median), Martial status (married), Age < 45, Education, literate, Place of residence, rural.
£ Duration lived in the area was treated as continuous variable.
**Adjusted coefficients were controlled for all other variables in the table.
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tors. However, the study also had various limitations.
Definitions of stigma often change across settings and
time and can be difficult to measure, as summarized by
Hotez et al. and reflected in several studies on TB and
HIV/AIDS-related stigma [38-41]. Although validated,
the scale may have some discrepancies across location or
time. A mixed methods approach was not used in this
study, so it lacked the qualitative depth displayed by
other studies such as that by Stienstra et al. which used
quantitative and qualitative data from interviews with
patients and control subjects to study stigma towards
Buruli ulcer [23]. Several groups were not studied to
gain a full understanding of podoconiosis stigma, includ-
ing community residents, health-care personnel, com-
munity leaders, and families of stigmatised individuals as
identified by Weiss et al. [14]. The study design also did
not allow for any comparisons of stigma across different
settings such as the study by Person et al. which com-
pared health-related stigma among women with lymph-
atic filariasis from the Dominican Republic and Ghana.
Antecedents, consequences, coping strategies and out-
comes indicated that Dominican women seemed far bet-
ter off than Ghanaians in their experience of stigma [20].
Lastly, the use of nurses as data collectors in the com-
munity may have also biased the results if subjects felt
pressurised to give answers or participate in the study
(due to power differentials between the nurses and com-
munity members or misunderstandings about the differ-
ence between clinical versus research objectives).
However, all research participants were informed about
the study’s objectives and told that participation in the
study would not affect their access to health services.
Conclusion
Podoconiosis has a clear social impact. These social con-
sequences and stigmatization are barriers to podoconio-
sis control and other research projects. Stigma related to
podoconiosis needs to be addressed within the context
of NTDs and global health. The link between global
health and stigma has been largely recognized as evi-
denced by programmes such as the initiative launched
by Fogarty International Center and partners and other
leading research [42]. Weiss et al. proposed the follow-
ing health-related stigma research priorities: (1) Docu-
ment the burden of stigma, (2) Identify determinants of
stigma and its effect, (3) Compare stigma for different
health problems or settings, (4) Evaluate stigma over
time or post-interventions, (5) Improve disease know-
ledge so that health policy minimises stigma, and (6) De-
velop appropriate messages about stigma [14]. This
paper begins to address the first two objectives as they
relate to podoconiosis, but further research is needed in
view of the limitations of this study. Furthermore,comparative or evaluation studies should be conducted
and evidence-based interventions to mitigate podoconio-
sis stigma should be pursued, particularly among pa-
tients with advanced disease stage.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
KD, EM, GD conceived the study. EM, KD, AT conducted the field work. EM &
KD conducted the analysis. KD, ST derafted the masnuscript. KD, ST, EM, AT
and GD interpreted the findings. All authors read and approved the final
manuscript.
Acknowledgment
This study was funded by IOCC Podoconiosis Research; Ethiopia. KD was
supported by TOMS Shoes for preparatory work of mapping podoconiosis in
Ethiopia during data collection, currently is supported by a Wellcome Trust
Research Training Fellowship [grant number 099876]. GD is supported by a
Wellcome Trust University award [grant number 091956] to do work in
podoconiosis.
Author details
1Brighton and Sussex Medical School, Falmer, Brighton, UK. 2School of Public
Health, Addis Ababa University, Addis Ababa, Ethiopia. 3Institute of Tropical
Medicine, Antwerp, Belgium. 4International Orthodox Christian Charities,
Debre Markos, Ethiopia.
Received: 14 July 2013 Accepted: 11 December 2013
Published: 13 December 2013
References
1. Davey G, Gebrehanna E, Adeyemo A, Rotimi C, Newport M, Desta K:
Podoconiosis: a tropical model for gene-environment interactions? Trans
R Soc Trop Med Hyg 2006, 101(1):91–96.
2. Ayele FT, Adeyemo A, Finan C, Hailu E, Sinnott P, Burlisnson ND, Aseffa A,
Rotimi CN, Newport MN, Davey G: HLA class II locus and susceptibility to
podoconiosis. N Engl J Med 2012, 366(13):1200–1208.
3. Davey G, Newport M: Podoconiosis: the most neglected tropical disease?
Lancet 2007, 369(9565):888–889.
4. Davey G: Podoconiosis, non-filarial elephantiasis, and lymphology.
Lymphology 2010, 43:168–177.
5. GebreHanna E: The social burden of podoocniosis and familial occurence in its
development. Ethiopia: Addis Ababa University; 2005.
6. Molla YB, Tomczyk S, Amberbir T, Tamiru A, Davey G: Podoconiosis in east and
west Gojam zones, Northern Ethiopia. PLoS Negl Trop Dis 2012, 6(7):e1744.
7. Yakob B, Deribe K, Davey G: Health professionals’ attitudes and
misconceptions regarding podoconiosis: potential impact on integration
of care in southern Ethiopia. Trans R Soc Trop Med Hyg 2010, 104(1):42–47.
8. Molla YB, Tomczyk S, Amberbir T, Tamiru A, Davey G: Patients’ perceptions
of podoconiosis causes, prevention and consequences in East and West
Gojam, Northern Ethiopia. BMC Public Health 2012, 12:828.
9. Yakob B, Deribe K, Davey G: High levels of misconceptions and stigma in
a community highly endemic for podoconiosis in southern Ethiopia.
Trans R Soc Trop Med Hyg 2008, 102(5):439–444.
10. Ayode D, McBride CM, de Heer HD, Watanabe E, Gebreyesus T, Tora A,
Tadele G, Davey G: A qualitative study exploring barriers related to use of
footwear in rural highland ethiopia: implications for neglected tropical
disease control. PLoS Negl Trop Dis 2013, 7(4):e2199.
11. Tekola F, Bull S, Farsides B, Newport MJ, Adeyemo A, Rotimi CN, Davey G:
Impact of social stigma on the process of obtaining informed consent
for genetic research on podoconiosis: a qualitative study. BMC Med Ethics
2009, 10:13.
12. Tora A, Davey G, Tadele G: A qualitative study on stigma and coping
strategies of patients with podoconiosis in Wolaita zone, Southern
Ethiopia. Int Health 2011, 3(3):176–181.
13. Mousley E, Deribe K, Tamiru A, Davey G: The impact of podoconiosis on
quality of life in Northern Ethiopia. Health Qual Life Outcomes 2013, 11(122).
14. Weiss MG, Ramakrishna J: Stigma interventions and research for
international health. Lancet 2006, 367(9509):536–538.
Deribe et al. BMC Public Health 2013, 13:1178 Page 8 of 8
http://www.biomedcentral.com/1471-2458/13/117815. Alonso LAJ: Stigmatizing neglected tropical diseases: a systematic review.
Soc Med 2010, 5(4):218–227.
16. Ribera J, Grietens K, Toomer E, Hausmann-Muela S: A word of caution
against the stigma trend in neglected tropical disease research and con-
trol. PLoS Negl Trop Dis 2009, 3(10):e445.
17. Franklin H, Tora A, Deribe K, Reda A, Davey G: Development of a scale to
measure stigma related to podoconiosis in Southern Ethiopia. BMC Public
Health 2013, 13:298.
18. Phraisuwan P, Whitney EAS, Tharmaphornpilas P, Guharat S,
Thongkamsamut S, Aresagig S, Liangphongphanthu J, Junthima K,
Sokampang A, Ashford DA: Leptospirosis: skin wounds and control
strategies, Thailand, 1999. Emerg Infect Dis 2002, 8(12):1455–1459.
19. Scrambler G: Stigma and disease: changing paradigms. Lancet 1998,
352(9133):1054–1055.
20. Person B, Bartholomew LK, Gyapong M, Addiss DG, van den Borne B:
Health-related stigma among women with lymphatic filariasis from the
Dominican Republic and Ghana. Soc Sci Med 2009, 68:30–38.
21. Grietens KP, Boock AU, Peeters H, Hausmann-Muela S, Toomer E, Ribera JM:
“It is me who endures but my family that suffers”: social isolation as a
consequence of the household cost burden of Buruli ulcer free of charge
hospital treatment. PLoS Negl Trop Dis 2008, 2(10):e321.
22. Kassi M, Kassi M, Afghan AK, Rehman R, Kasi PM: Marring Leishmaniasis:
The stigmatization and the impact of cutaneous leishmaniasis in
Pakistan and Afghanistan. PLoS Negl Trop Dis 2008, 2(10):e259.
23. Stienstra Y, van der Graaf WA, Asamoa K, van der Werf T: Beliefs and
attitudes toward Buruli Ulcer in Ghana. Am J Trop Med 2002,
67(2):207–213.
24. Takougang I, Meli J, Fotso S, Angwafo F III, Kamajeu R, Ndumbe P: Some
social determinants of urinary schistosomiasis in Northern Cameroon:
Implications for schistosomiasis control. Afr J Health Sci 2004,
11(3–4):111–120.
25. Vlassoff C, Weiss M, Ovuga EBL, Eneanya C, Nwel PT, Babalola SS, Awedoba
AK, Theophilus B, Cofie P, Shetabi P: Gender and the stigma of
onchocercal skin disease in Africa. Soc Sci Med 2000, 50:1353–1368.
26. Zeldenryk LM, Gray M, Speare R, Gordon S, Melrose W: The emerging story
of disability associated with lymphatic filariasis: a critical review. PLoS
Negl Trop Dis 2011, 5(12):e1366.
27. Perera M, Whitehead M, Molyneux D, Weerasooriya M, Gunatileke G:
Neglected patients with a neglected disease? A qualitative study of
lymphatic filariasis. PLoS Negl Trop Dis 2007, 1(2):e128.
28. Weiss MG: Stigma and the social burden of neglected tropical diseases.
PLoS Negl Trop Dis 2008, 2(5):e237.
29. Person B, Bartholomew LK, Addiss D, van den Borne B: Disrupted social
connectedness among Dominican women with chronic filarial
lymphedema. Patient Educ Couns 2007, 68(3):279–286.
30. van Brakel WH: Measuring leprosy stigma-a preliminary review of the lep-
rosy literature. Int J Lepr 2003, 71(3):190–197.
31. Opala J, Boillot F: Leprosy among the Limba: illness and healing in the
context of world view. Soc Sci Med 1996, 42(1):3–19.
32. Brieger W, Oshiname F, Ososanya O: Stigma associated with onchocercal
skin disease among those affected near the Ofiki and Oyan rivers in
western Nigeria. Soc Sci Med 1998, 47(7):841–852.
33. Pearson M: What does distance matter? Leprosy control in West Nepal.
Soc Sci Med 1988, 26(1):25–36.
34. Yanik M, Gurel M, Kati M: The psychological impact of cutaneous
leishmaniasis. Clin Exp Dermatol 2004, 29:464–467.
35. Kumari A, Harichandrakumar K, Das L, Krishnamoorthy K: Physical and
psychosocial burden due to lymphatic filariasis as perceived by patients
and medical experts. Trop Med Int Health 2005, 10(6):567–573.
36. Central Statistical Agency of Ethiopia: Office of Population and Housing
Census Commission: 2007 Population and Housing Census of Ethiopia: Results
for Amhara Region. Ethiopia: Population size and characteristics Addis
Ababa; 2008. [http://www.csa.gov.et/]
37. Tsutsumi A, Izutsu T, Islam AM, Maksuda AN, Kato H, Wakai S: The quality of
life, mental health, and perceived stigma of leprosy patients in
Bangladesh. Soc Sci Med 2007, 64(12):2443–2453.
38. Somma D, Thomas B, Karim F, Kemp J, Arias N, Auer C, Gonsoniu G,
Abouihla A, Weiss M: Gender and socio-cultural determinants of TB-
related stigma in Bangladesh, India, Malawi and Colombia. Int J Tuberc
Lung Dis 2008, 12(7):856–866.39. Infante C, Aggleton P, Pridmore P: Forms and determinants of migration
and HIV/AIDS-related stigma on the Mexican-Guatemalan border. Qual
Health Res 2009, 19(12):1656–1668.
40. Wong LP: Prevalence and factors associated with HIV/AIDS-related stigma and
discriminatory attitudes: a cross-sectioal nationwide study. Prev Med 2013,
57(Suppl):S60-63.
41. Hotez PJ: Stigma: the stealth weapon of the NTD. PLoS Negl Trop Dis 2008,
2(4):e230.
42. Michels KM, Hofman KJ, Keusch GT, Hrynkow SH: Stigma and global health:
looking forward. Lancet 2006, 367(9509):538–539.
doi:10.1186/1471-2458-13-1178
Cite this article as: Deribe et al.: Stigma towards a Neglected Tropical
Disease: Felt and enacted Stigma Scores among Podoconiosis Patients
in Northern Ethiopia. BMC Public Health 2013 13:1178.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
